Literature DB >> 17189716

Aneuploidy acts both oncogenically and as a tumor suppressor.

Beth A A Weaver1, Alain D Silk, Cristina Montagna, Pascal Verdier-Pinard, Don W Cleveland.   

Abstract

An abnormal chromosome number, aneuploidy, is a common characteristic of tumor cells. Boveri proposed nearly 100 years ago that aneuploidy causes tumorigenesis, but this has remained untested due to the difficulty of selectively generating aneuploidy. Cells and mice with reduced levels of the mitosis-specific, centromere-linked motor protein CENP-E are now shown to develop aneuploidy and chromosomal instability in vitro and in vivo. An increased rate of aneuploidy does drive an elevated level of spontaneous lymphomas and lung tumors in aged animals. Remarkably, however, in examples of chemically or genetically induced tumor formation, an increased rate of aneuploidy is a more effective inhibitor than initiator of tumorigenesis. These findings reveal a role of aneuploidy and chromosomal instability in preventing tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17189716     DOI: 10.1016/j.ccr.2006.12.003

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  352 in total

1.  Centromere-associated protein E expresses a novel mRNA isoform in acute lymphoblastic leukemia.

Authors:  Cindy E Jiménez-Ávila; Vanessa Villegas-Ruíz; Marta Zapata-Tarres; Alejandra E Rubio-Portillo; Eleazar I Pérez López; Juan C Zenteno; Sergio Juárez-Méndez
Journal:  Int J Mol Epidemiol Genet       Date:  2018-10-20

2.  Germline PKHD1 mutations are protective against colorectal cancer.

Authors:  Christopher J Ward; Yanhong Wu; Ruth A Johnson; John R Woollard; Eric J Bergstralh; Mine S Cicek; Jason Bakeberg; Sandro Rossetti; Christina M Heyer; Gloria M Petersen; Noralene M Lindor; Stephen N Thibodeau; Peter C Harris; Vicente E Torres; Marie C Hogan; Lisa A Boardman
Journal:  Hum Genet       Date:  2011-01-28       Impact factor: 4.132

3.  CENP-E kinesin interacts with SKAP protein to orchestrate accurate chromosome segregation in mitosis.

Authors:  Yuejia Huang; Wenwen Wang; Phil Yao; Xiwei Wang; Xing Liu; Xiaoxuan Zhuang; Feng Yan; Jinhua Zhou; Jian Du; Tarsha Ward; Hanfa Zou; Jiancun Zhang; Guowei Fang; Xia Ding; Zhen Dou; Xuebiao Yao
Journal:  J Biol Chem       Date:  2011-11-22       Impact factor: 5.157

Review 4.  Let's huddle to prevent a muddle: centrosome declustering as an attractive anticancer strategy.

Authors:  A Ogden; P C G Rida; R Aneja
Journal:  Cell Death Differ       Date:  2012-06-01       Impact factor: 15.828

5.  Replication-compromised cells require the mitotic checkpoint to prevent tetraploidization.

Authors:  Zilai Zhang; Sumit Arora; Yanjiao Zhou; Athena Cherry; Teresa S-F Wang
Journal:  Chromosoma       Date:  2010-09-09       Impact factor: 4.316

6.  Targeting a kinetochore-associated motor protein to kill cancer cells.

Authors:  Sarah A Wacker; Tarun M Kapoor
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-22       Impact factor: 11.205

7.  Nuclear pores protect genome integrity by assembling a premitotic and Mad1-dependent anaphase inhibitor.

Authors:  Veronica Rodriguez-Bravo; John Maciejowski; Jennifer Corona; Håkon Kirkeby Buch; Philippe Collin; Masato T Kanemaki; Jagesh V Shah; Prasad V Jallepalli
Journal:  Cell       Date:  2014-02-27       Impact factor: 41.582

Review 8.  Cell cycle, CDKs and cancer: a changing paradigm.

Authors:  Marcos Malumbres; Mariano Barbacid
Journal:  Nat Rev Cancer       Date:  2009-03       Impact factor: 60.716

9.  Constitutive Cdk2 activity promotes aneuploidy while altering the spindle assembly and tetraploidy checkpoints.

Authors:  Stephan C Jahn; Patrick E Corsino; Bradley J Davis; Mary E Law; Peter Nørgaard; Brian K Law
Journal:  J Cell Sci       Date:  2013-01-15       Impact factor: 5.285

10.  Sgt1 dimerization is required for yeast kinetochore assembly.

Authors:  Parmil K Bansal; Amanda Nourse; Rashid Abdulle; Katsumi Kitagawa
Journal:  J Biol Chem       Date:  2008-12-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.